(Q48563190)

12 February 2018

title

Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. (English)

1 reference

12 February 2018

0 references

Susan E Spiller

1

1 reference

12 February 2018

Ali C Ravanpay

series ordinal

2

1 reference

12 February 2018

Andrew W Hahn

series ordinal

3

1 reference

12 February 2018

James M Olson

series ordinal

4

1 reference

12 February 2018

publication date

28 April 2006

1 reference

12 February 2018

Journal of Neuro-Oncology

published in

1 reference

12 February 2018

volume

79

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

259-270

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-006-9142-0

exact match

0 references

cites work

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

1 reference

12 December 2020

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

1 reference

12 December 2020

Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA)

1 reference

12 December 2020

p15INK4b in HDAC inhibitor‐induced growth arrest

1 reference

12 December 2020

Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells

1 reference

12 December 2020

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

12 December 2020

BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect.

1 reference

12 December 2020

Different accessibilities in chromatin to histone acetylase

1 reference

12 December 2020

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

1 reference

12 December 2020

Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate

1 reference

12 December 2020

Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study

1 reference

12 December 2020

Late neurocognitive sequelae in survivors of brain tumours in childhood

1 reference

12 December 2020

Medulloblastoma growth inhibition by hedgehog pathway blockade

1 reference

12 December 2020

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

12 December 2020

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

12 December 2020

Prognostic significance of apoptosis in medulloblastoma.

1 reference

12 December 2020

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

1 reference

12 December 2020

Identification of genes that are regulated transcriptionally by Myc in childhood tumors

1 reference

12 December 2020

Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen

1 reference

12 December 2020

Medulloblastoma: signalling a change in treatment

1 reference

12 December 2020

The BRCA2 is a histone acetyltransferase

1 reference

12 December 2020

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

1 reference

12 December 2020

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

12 December 2020

Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5

1 reference

12 December 2020

Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo

1 reference

12 December 2020

The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas

1 reference

12 December 2020

10.1007/S11060-006-9142-0

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018